GENF vs. RLM, NSCI, IXI, OPTI, OBD, SNG, BVX, CIZ, TCF, and EVG
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Realm Therapeutics (RLM), NetScientific (NSCI), IXICO (IXI), OptiBiotix Health (OPTI), Oxford BioDynamics (OBD), Synairgen (SNG), BiVictriX Therapeutics (BVX), Cizzle Biotechnology (CIZ), Theracryf (TCF), and Evgen Pharma (EVG). These companies are all part of the "biotechnology" industry.
Genflow Biosciences vs. Its Competitors
Realm Therapeutics (LON:RLM) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.
Realm Therapeutics has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks.
Genflow Biosciences has a net margin of 778.46% compared to Realm Therapeutics' net margin of 0.00%. Realm Therapeutics' return on equity of 0.00% beat Genflow Biosciences' return on equity.
0.9% of Genflow Biosciences shares are held by institutional investors. 42.8% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Realm Therapeutics' average media sentiment score of 0.00 equaled Genflow Biosciences'average media sentiment score.
Summary
Realm Therapeutics and Genflow Biosciences tied by winning 4 of the 8 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
This page (LON:GENF) was last updated on 9/13/2025 by MarketBeat.com Staff
Free GENF Stock Alerts